6 employees
Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.
2015
$8.8M
from 1 investors over 1 rounds
NeuroTherapia, Inc. raised $8.8M on September 22, 2020
Investors: Dolby Family Ventures